| dc.creator |
Yilmaz, Gülruhsar |
|
| dc.creator |
Tasyaran, Mehmet A. |
|
| dc.creator |
KOÇAK TUFAN, ZELİHA |
|
| dc.creator |
Izdes, Seval |
|
| dc.creator |
Guven, Tumer |
|
| dc.creator |
Acikgoz, Ziya Cibali |
|
| dc.creator |
Guner, Rahmet |
|
| dc.date |
2015-04-30T21:00:00Z |
|
| dc.date.accessioned |
2021-01-21T09:10:24Z |
|
| dc.date.available |
2021-01-21T09:10:24Z |
|
| dc.identifier |
f0d38f93-6703-4eef-b126-457a1ef39558 |
|
| dc.identifier |
10.3855/jidc.6195 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/f0d38f93-6703-4eef-b126-457a1ef39558/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/88898 |
|
| dc.description |
Introduction: Colistin use has increased over the last ten years because of multidrug-resistant microorganisms. The aim of this study was to compare the clinical and microbiological efficacy of colistin alone or in combination with sulbactam or carbapenem in the treatment of ventilator-associated pneumonia (VAP) due to multidrug-resistant (MDR) and extremely drug-resistant (XDR) A. baumannii. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia |
|
| dc.type |
info:eu-repo/semantics/article |
|